Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ezetimibe tablets
DRUG
3 trials
Sponsors
Federico II University
, Cao Yu
, NYU Langone Health
Conditions
Postprandial Lipemia
Therapeutic Equivalency
Type 1 Diabetes
Type 2 Diabetes
Phase 1
Bioequivalence of Ezetimibe Tablets in Healthy Subjects
NCT04814589
Cao Yu
Therapeutic Equivalency
Start: 2021-03-13
End: 2021-07-31
Target: 96
Updated: 2021-03-24
Phase 4
Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes
Completed
NCT00699023
Federico II University
Postprandial Lipemia, Type 2 Diabetes
Start: 2008-06-30
End: 2009-10-31
Target: 13
Updated: 2009-11-04
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Recruiting
NCT05641753
NYU Langone Health
Type 1 Diabetes
Start: 2022-12-06
End: 2027-07-31
Target: 125
Updated: 2025-12-29
Related Papers
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
2011-03-15
50 citations